𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Expression of human intestinal trefoil factor in malignant cells and its regulation by oestrogen in breast cancer cells

✍ Scribed by May, Felicity E. B.; Westley, Bruce R.


Publisher
John Wiley and Sons
Year
1997
Tongue
English
Weight
420 KB
Volume
182
Category
Article
ISSN
0022-3417

No coin nor oath required. For personal study only.

✦ Synopsis


Human intestinal trefoil factor (hITF) is a small cysteine-rich protein expressed in the gastrointestinal (GI) tract. Its sequence is related to that of other trefoil peptides including the pNR-2/pS2 protein, which is regulated by oestrogen in breast cancer. This study was designed to investigate whether hITF is expressed in human carcinoma cells. cDNA was obtained by reverse transcription-polymerase chain reaction (RT-PCR) of gastric mucosal RNA and sequenced, establishing that this mRNA is expressed in the stomach. Expression of hITF was detected in a proportion of cell lines derived from malignancies of the GI tract, in hepatocellular carcinoma cells, and at highest levels in a small cell lung carcinoma cell line. Amongst breast cancer cell lines, it was expressed in all the oestrogen-responsive but in none of the oestrogen-nonresponsive breast cancer cell lines. The possibility that hITF expression in breast cells is controlled by oestradiol was then tested. Oestradiol treatment increased hITF expression between three-and ten-fold in the oestrogen-responsive breast cancer cell lines, demonstrating that, like pNR-2/pS2, hITF is regulated by oestrogen in breast cancer cells. Tamoxifen inhibited the induction of hITF expression by oestradiol but tamoxifen alone was a partial oestrogen agonist for hITF expression. These results show that hITF is expressed, sometimes ectopically, in several human malignancies, which suggests that trefoil peptides may have a more general role in tumourigenesis than hitherto appreciated. That the expression of hITF is regulated by oestrogen in breast cancer cells suggests that hITF expression may provide a novel marker for oestrogen responsiveness in breast cancer.


πŸ“œ SIMILAR VOLUMES


Expression profile of agonistic Smads in
✍ Frederic Pouliot; Claude Labrie πŸ“‚ Article πŸ“… 1999 πŸ› John Wiley and Sons 🌐 French βš– 153 KB πŸ‘ 1 views

Transforming growth factor-␀1 (TGF-␀1) is a cytokine expressed by mammary cells. While TGF-␀1 can inhibit the proliferation of human breast cancer cells, many cell lines are unresponsive to it. To shed light on the mechanisms underlying resistance to TGF-␀1, we examined expression of the mediators o

Expression and regulation of the meprin
✍ Gail L. Matters; Judith S. Bond πŸ“‚ Article πŸ“… 1999 πŸ› John Wiley and Sons 🌐 English βš– 246 KB πŸ‘ 1 views

A novel mRNA isoform (meprin b H ) of the cell-surface protease subunit meprin b was previously identified in human colon cancer cells. The study reported here revealed that this mRNA isoform was identical within the protein coding region and at the 3 H end to the b isoform of normal intestine but t

Examination of POU homeobox gene express
✍ Tianru Jin; Donald R. Branch; Xiaoyun Zhang; Shangle Qi; Bruce Youngson; Paul E. πŸ“‚ Article πŸ“… 1999 πŸ› John Wiley and Sons 🌐 French βš– 355 KB πŸ‘ 2 views

Abnormal expression of homeobox genes may lead to the development of leukemias, lymphomas, and solid tumors. Expression of homeobox genes in mammary glands, however, has not been studied actively until recently. We have examined the expression of POU homeobox genes in human breast cancer cell lines

Expression of bone morphogenetic protein
✍ Joachim H. Clement; JΓΆrg SΓ€nger; Klaus HΓΆffken πŸ“‚ Article πŸ“… 1999 πŸ› John Wiley and Sons 🌐 French βš– 219 KB πŸ‘ 2 views

Bone morphogenetic proteins (BMPs) are multifunctional regulators of proliferation, differentiation and apoptosis. BMP-6 is involved in numerous developmental processes. We have demonstrated expression of BMP-6 in breast cancer cell lines by RT-PCR and immuno-histochemistry. The level of BMP-6 mRNA